Gene · 4762
Papers2,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dissecting the epigenomic differences between smoking and nicotine dependence in a veteran cohort. | Addict Biol | 2023 | 36577721 | PubTator, text mining | PubMed |
| Self-Assembled Matrigel-Free iPSC-Derived Liver Organoids Demonstrate Wide-Ranging Highly Differentiated Liver Functions. | Stem Cells | 2023 | 36573434 | PubTator, text mining | PubMed |
| BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network. | Nature | 2023 | 36544023 | PubTator, text mining | PubMed |
| When caring becomes an art - how clinical gaze are perceived to be developed. | Int J Qual Stud Health Well-being | 2023 | 36482509 | PubTator, text mining | PubMed |
| MSC based gene delivery methods and strategies improve the therapeutic efficacy of neurological diseases. | Bioact Mater | 2023 | 36474656 | PubTator, text mining | PubMed |
| Advances in biomimetic collagen mineralisation and future approaches to bone tissue engineering. | Biopolymers | 2023 | 36444710 | PubTator, text mining | PubMed |
| Mitochondrial [2Fe-2S] ferredoxins: new functions for old dogs. | FEBS Lett | 2023 | 36443530 | PubTator, text mining | PubMed |
| A conflicted tribe under pressure: A qualitative study of negative workplace behaviour in nursing. | J Adv Nurs | 2023 | 36394212 | PubTator, text mining | PubMed |
| Inhibition of DNMT3B and PI3K/AKT/mTOR and ERK Pathways as a Novel Mechanism of Volasertib on Hypomethylating Agent-Resistant Cells. | Biomol Ther (Seoul) | 2023 | 36382510 | PubTator, text mining | PubMed |
| Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulation. | Cancer Sci | 2023 | 36285482 | PubTator, text mining | PubMed |
| Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2. | Nat Chem Biol | 2023 | 36280795 | PubTator, text mining | PubMed |
| Developmental toxicity of prometryn induces mitochondrial dysfunction, oxidative stress, and failure of organogenesis in zebrafish (Danio rerio). | J Hazard Mater | 2023 | 36272374 | PubTator, text mining | PubMed |
| Risk factors for COVID-19 virus infection among health workers: A case-control study in the Bono East Region of Ghana. | Am J Infect Control | 2023 | 35970420 | PubTator, text mining | PubMed |
| Engineering circular RNA for enhanced protein production. | Nat Biotechnol | 2023 | 35851375 | PubTator, text mining | PubMed |
| RREB1::MRTFB fusion-positive extra-glossal mesenchymal neoplasms: A series of five cases expanding their anatomic distribution and highlighting significant morphological and phenotypic diversity. | Genes Chromosomes Cancer | 2023 | 35763541 | PubTator, text mining | PubMed |
| Gene expression changes implicate specific peripheral immune responses to Deep and Lobar Intracerebral Hemorrhages in humans. | Brain Hemorrhages | 2022 | 36936603 | PubTator, text mining | PubMed |
| Perspective: Collagen induced platelet activation via the GPVI receptor as a primary target of colchicine in cardiovascular disease. | Front Cardiovasc Med | 2022 | 36741844 | PubTator, text mining | PubMed |
| Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection. | Front Immunol | 2022 | 36741401 | PubTator, text mining | PubMed |
| Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients. | Front Immunol | 2022 | 36713433 | PubTator, text mining | PubMed |
| Association of environmental exposure to chromium with differential DNA methylation: An epigenome-wide study. | Front Genet | 2022 | 36685967 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4762/papers?page=12